Organization
Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany
99 abstracts
Abstract
Evolution of quality of life (QoL) and symptom burden (SB) in patients receiving inpatient palliative care (PC) following one week of care in a specialized palliative care unit (PCU): A comparison of two groups, with one receiving specialized outpatient palliative care prior to admission.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Sarcoma Center Berlin-Brandenburg, Helios Hospital Bad Saarow, Bad Saarow, Germany, Helios Klinikum Bad Saarow-Sarcoma Center Berlin-Brandenburg and University Medicine Greifswald, Bad Saarow, Germany,
Abstract
Race and decisional conflict about genetic testing in patients with advanced prostate cancer.Org: Henry Ford Hospital, Henry Ford Health System, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Henry Ford Cancer Institute, Detroit, MI,
Abstract
KANSURVIVE: Testing a telementoring model for improving cancer survivorship care in rural practice.Org: University of Kansas Medical Center, Department of Biostatistics & Data Science, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Kansas Cancer Center, Kansas City, KS,
Abstract
Oncologic outpatient specialty palliative care referral utilization: A single institution quality improvement project.Org: University of Kansas Medical Center, Department of Biostatistics & Data Science, Division of Gynecologic Oncology, University of Pennsylvania, University of Kansas School of Medicine - Wichita, University of Kansas Cancer Center, Kansas City, KS, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Real world outcome of patients with multiple myeloma who received bispecific antibodies after CAR-T therapy.Org: Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, Mayo Clinic, Mayo Clinic Rochester, Rochester, MN, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
End-of-life care preferences in patients with gallbladder cancer: Shifting patterns and disparities over two decades.Org: Roswell Park Comprehensive Cancer Center, Karachi Medical and Dental College, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, William Beaumont University Hospital, Corewell Health William Beaumont University Hospital,
Abstract
Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)–targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM).Org: Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Yale School of Medicine, Yale New Haven Hospital, H. Lee Moffitt Cancer Center and Research Institute,
Abstract
A multi-institutional observer study of AI-aided oncologists' performance on treatment response assessment of bladder cancer.Org: Penn State Cancer Institute, University of Michigan, University of Iowa Holden Comprehensive Cancer Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan,
Abstract
Mutations and mortality in very young patients with breast cancer.Org: Ochsner Clinic Foundation, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Ochsner Health Center,
Abstract
Impact of protein energy malnutrition on hospitalized patients with acute myeloid and lymphoid leukemia: A United States population-based cohort study.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Jefferson-Einstein Hospital, Internal Medicine Residency, Einstein Medical Center Philadelphia, Jefferson Einstein Medical Center,
Abstract
Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, William Beaumont University Hospital,
Abstract
The association of protein-energy malnutrition and in-hospital clinical outcomes among patients with colorectal cancer hospitalized for gastrointestinal bleeding: A nationwide analysis.Org: University of Missouri School of Medicine, Johns Hopkins University Bloomberg School of Public Health, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Jefferson-Einstein Hospital,
Abstract
Impact of delirium on outcomes among hospitalized patients with colorectal cancer: A United States population-based cohort study.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Jefferson-Einstein Hospital, Jefferson Einstein Medical Center,
Abstract
A phase II study of nivolumab in patients with recurrent or metastatic carcinosarcomas.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Seoul National University Hospital, Division of Hematology-Oncology, Department of Medicine, Seoul Medical Center, Seo-Gu, South Korea, Department of Medicine, Icahn School of Medicine at Mount Sinai, Samsung Medical Center,
Abstract
Unlocking therapeutic potential: IL-1β as a target in non-small cell lung cancer with oncogenic mutations—Prognostic and predictive insights.Org: Loma Linda University Department of Radiation Technology, Department of Oncology/Hematology, Loma Linda University Medical Center, Division of Hematology/ Oncology, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
First relapse in patients with multiple myeloma: Outcomes and predictors.Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic Rochester, Rochester, MN, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ,
Abstract
Routine documentation of pre-treatment functional variables to predict survival in patients on immunotherapy.Org: Department of Hematology & Oncology, College of Medicine, University of Oklahoma Health Sciences Center, Wake Forest Baptist Medical Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Atrium Health Wake Forest Baptist Medical Center, Wake Forest University School of Medicine,
Abstract
Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review.Org: ATTIKON University Hospital, Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Faculty of Medicine, Cairo University, National and Kapodistrian University of Athens,
Abstract
Improving clinical outcomes in multiple myeloma: Weight maintenance strategies to reduce complications during autologous hematopoietic transplantation.Org: Augusta University/University of Georgia Medical Partnership, Georgia Cancer Center, Augusta University, Medical College of Georgia, Augusta, GA, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Positive baseline thyroid autoantibodies as a predictive biomarker for thyroid immune-related adverse events: A systematic review and meta-analysis.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Missouri–Kansas City School of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, John A. Burns School of Medicine, University of Hawaii Cancer Center,
Abstract
Impact of treatment approaches in patients with advance penile cancer: An analysis from a nationwide study.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, William Beaumont University Hospital, Royal Oak, MI,
Abstract
Lorlatinib in TKI naïve, advanced ROS1-positive non-small-cell lung cancer: A multicenter, open-label, single-arm, phase 2 trial.Org: Center for Lung Cancer, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Research Institute and Hospital, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Racial differences in degrees of side effects to taxane based chemotherapy in patients with breast cancer.Org: Ochsner Health System, New Orleans, LA, Ochsner Health Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Ochsner Clinic Foundation,
Abstract
Global retrospective study comparing consolidation ALK tyrosine kinase inhibitors (TKI) to durvalumab (durva) or observation (obs) after chemoradiation (CRT) in unresectable locally-advanced ALK+ non-small cell lung cancer (NSCLC).Org: Yale New Haven Hospital, Yale Cancer Center, Yale School of Medicine, New Haven, CT, Princess Margaret Cancer Centre, University Health Network, Massachusetts General Hospital,
Abstract
WITHDRAWN: Age-defined outcomes in patients with breast cancer treated with aromatase inhibitor therapy: Insights from a National Inpatient Sample Database analysis.Org: University of California, Riverside, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Community Hospital of San Bernardino, Trumbull Regional Medical Center, Western Reserve Health Education,
Abstract
Impact of DNA damage repair alterations on real-world response to therapy in metastatic colorectal cancer.Org: Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Outcomes among hospitalized patients with colorectal cancer and comorbid congestive heart failure: A United States population-based cohort study.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Jefferson-Einstein Hospital, Jefferson Einstein Medical Center,
Abstract
Real world outcomes with cabazitaxel (cab) plus carboplatin (car) in metastatic castration-resistant prostate cancer (mCRPC).Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Emory School of Medicine, Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, Emory University School of Medicine, Winship Cancer Institute of Emory University,
Abstract
Effect of demographic and clinician factors on patients' likelihood of pursuing hereditary cancer genetic testing.Org: University of Michigan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Michigan School of Public Health, Rogel Cancer Center,
Abstract
Costs and access barriers to ondansetron: A national analysis of Medicare part D and Medicare Advantage plans.Org: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Dallas, TX, UT Southwestern Medical Center,
Abstract
Phase II study of durvalumab plus olaparib as maintenance therapy in extensive-stage small-cell lung cancer (TRIDENT): Preliminary efficacy and safety results.Org: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Affiliated Dongguan Hospital, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital,
Abstract
Real-world impact of TAILORx on chemotherapy use and SOFT/TEXT on ovarian function suppression uptake in a population based-cohort of women 40 years and under with HR-positive, HER2-negative, axillary lymph node negative breast cancer.Org: Schulich School of Medicine and Dentistry, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Western University, London Health Sciences Center, Tom Baker Cancer Centre,
Abstract
Longitudinal assessment of cardiac involvement in Erdheim-Chester disease using cardiac magnetic resonance imaging.Org: Hôpital Pitié-Salpêtrière, Service de Médecine Interne 2, Hôpital Pitié Salpêtrière, Assistance Publique Hôpitaux de Paris (AP-HP), Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah, Huntsman Cancer Institute, Intermountain Medical Center,
Abstract
A phase I study of nelmastobart (hSTC810), an anti-BTN1A1 antibody, in patients with advanced solid tumors.Org: Korea University Anam Hospital, Yonsei Cancer Center, Yonsei University Health System, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Yonsei University College of Medicine,
Abstract
The clinical feasibility of circulating tumor DNA alterations in patients with advanced hepatocellular carcinoma.Org: Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, CHA Bundang Medical Center, CHA University School of Medicine, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Medical Oncology Group,
Abstract
OMNIA-2: Phase I/II study of ANV419, an IL-2R-βγ targeted antibody-IL-2 fusion protein, in patients with relapsed or refractory multiple myeloma.Org: Anaveon, Institute of Medical Oncology, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Lillebaelt Hospital, University Hospital of Southern Denmark,
Abstract
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.Org: Mayo Clinic, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery.Org: Yonsei University College of Medicine, Netherlands Comprehensive Cancer Organisation (IKNL), Yonsei Cancer Center, Yonsei University Health System, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Molecular subtypes from comprehensive clustering from multi-omics dataset to predict the therapeutic efficacy of immunotherapeutic agent-based treatments in advanced hepatocellular carcinoma.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, CHA Bundang Medical Center, CHA University School of Medicine, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Medical Oncology Group,
Abstract
The metabolic activity assessed by 18F-FDG PET and its correlation with tumor immune status and prognosis in advanced biliary tract cancer patients treated with 1L GemCis plus durvalumab +/-tremelimumab.Org: Medical Oncology Group, Seoul National University Hospital, Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Trends in mortality caused by neoplasms of the heart in the United States between 2000 and 2019: An observational analysis of disparities by gender and race.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Mount Auburn Hospital, Lahey Hospital and Medical Center, Burlington, MA,
Abstract
Epidemiologic characteristics, treatment patterns, and survival analysis of plasmablastic lymphoma in the US.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah, Hunstman Cancer Institute at the University of Utah,
Abstract
Infrastructure for rare cancer in the Netherlands: Towards a comprehensive platform for early detection and diagnosis of rare cancers (FORCE).Org: The Netherlands Cancer Institute, Amsterdam/UMC Utrecht ENETS Centre of Excellence, Department of Endocrine Oncology, University Medical Center Groningen, Máxima Medical Center,
Abstract
Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA).Org: Novartis Pharma AG, Novartis Oncology, Genesis Research, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Yale School of Medicine,
Abstract
Biomarkers of response to sacituzumab govitecan (SG) and efficacy after treatment with enfortumab vedotin (EV) in advanced urothelial carcinoma (aUC): Analysis of the UNITE study.Org: University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, MD Anderson Hematology/Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Washington and Fred Hutchinson Cancer Research Centre,
Abstract
Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25).Org: Gangnam Severance Hospital, Yonesi University College of Medicine, Gangnam-Gu, Nacuity Pharmaceuticals, Korea United Pharmaceuticals Inc.,
Abstract
Positive margin and advanced depth of invasion as the indicators for assessing the necessity of adjuvant chemoradiotherapy in early-stage oral cavity squamous cell carcinoma.Org: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Chung Shan Medical University Hospital, Department of Dentistry, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,
Abstract
Comprehensive geriatric assessment based multidisciplinary team intervention for hospitalized frail patients in oncology: COMPASS-ONCO/KCSG AL21-13.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, Division of Hematology/Oncology, Department of Medicine, University Of Toledo,
Abstract
Racial disparities in the prevalence of extrathoracic metastases in lung cancer patients and survival: A SEER database study (2010–2019).Org: Seidman Cancer Center, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
Hospitalization for immune related toxicity and overall survival (OS) among patients with metastatic non-small cell lung cancer (NSCLC) treated with first-line pembrolizumab.Org: The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, Ohio State University Comprehensive Canvcer Hospital, Center for Biostatistics and Department of Biomedical Informatics, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center and Comprehensive Cancer Center,
Abstract
Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.Org: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, University of Colorado Denver Anschutz Medical Center, Aurora, CO,
Abstract
Academic medical center access and outcomes in Kaposi sarcoma.Org: Creighton University School of Medicine Phoenix Regional Campus, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
Single center experience of using Anakinra prophylactically at Day 0 to reduce CD19 CART toxicities.Org: Augusta University Georgia Cancer Center, University of Illinois Urbana-Champaign, College of Medicine, University of the Philippines - Manila, Medical College of Georgia, Augusta, GA, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Trends of using immune checkpoint inhibitors near end of life in limited resources setting: Experience of single cancer center in the MENA region.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, King Hussein Cancer Center, KHCC,
Abstract
Genetic testing outcomes and pathogenic germline mutation prevalence in renal cell carcinoma.Org: Rogel Comprehensive Cancer Center, University of Michigan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Division of Metabolism, Endocrinology, and Diabetes,
Abstract
Safety of concurrent use of radiotherapy for second primary malignancy (SPM) in patients with chronic lymphocytic leukemia (CLL) receiving novel agent therapy.Org: Mayo Clinic, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Division of Clinical Trials and Biostatistics,
Abstract
Longitudinal trends in serum calcium, parathormone and bone mineral density in breast cancer survivors on aromatase inhibitor therapy: A single institutional cohort study.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Cleveland Clinic Taussig Cancer Instititute, University of Pittsburgh Medical Center, Endocrinology and metabolic institute, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.Org: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, The Ohio State University - James Cancer Hospital, Ohio State University College of Medicine, The Ohio State University Medical Center,
Abstract
Cost-effectiveness analysis of a circulating tumor DNA-based molecular residual disease assay to guide adjuvant chemotherapy decisions in patients with resectable early stage colorectal cancer.Org: Avalon Health Economics, Schulich School of Medicine and Dentistry, Department of Surgery, Brigham and Women's Hospital, Boston, MA, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Immune-related hypophysitis: An analysis of a heterogeneous entity.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Cleveland Clinic Taussig Cancer Instititute, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
The timing of statin initiation on survival outcomes of cancer patients treated with immune checkpoint inhibitors: A retrospective cohort study.Org: Unity Hospital, Rochester Regional Health System, Department of Medical Education, Kuang Tien General Hospital, Mount Auburn Hospital,
Abstract
Characterizing non-small cell lung cancer driven by mutations in ARAF and CRAF family members.Org: Ohio State University Comprehensive Canvcer Hospital, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, James Thoracic Center, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH,
Abstract
Deep learning-based ensemble model using hematoxylin and eosin (H&E) whole slide images (WSIs) for the prediction of MET mutations in non-small cell lung cancer (NSCLC).Org: Samsung Medical Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Division of Hematology-Oncology, Department of Medicine, Seoul Medical Center, Seo-Gu, South Korea, Sungkyunkwan University School of Medicine, Samsung Medical Hospital,
Abstract
Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis.Org: Albert Einstein College of Medicine, Jacobi Medical Center/North Central Bronx, Bronx, NY, Albert Einstein College of Medicine - Montefiore Medical Center, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
Comprehensive genomic analysis for homologous recombination deficiency in pancreatic cancer.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea,
Abstract
Impact of disadvantaged socioeconomic and demographic status on survival in Kaposi sarcoma.Org: Creighton University School of Medicine Phoenix Regional Campus, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
Survival outcomes in duodenal carcinoma based on facility type: A National Cancer Database analysis.Org: Creighton University Medical Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Creighton University School of Medicine Phoenix Regional Campus, Fred & Pamela Buffett Cancer Center, Creighton Hematology Oncology, Omaha, NE,
Abstract
Response monitoring with ctDNA in metastatic pancreatic cancer.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul National University Hospital,
Abstract
Diagnostic performance of natural language processing in detection of acute cancer VTE.Org: University of Texas MD Anderson Cancer Center, UT Health Sciences Center at Houston, The University of Texas Health Science Center McGovern Medical School, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Department of Analytics and Informatics,
Abstract
Trends and survival of malignant mesothelioma across racial groups between 2000-2019: A real-world study.Org: Seidman Cancer Center, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
Real world genomics in metastatic urothelial carcinoma (mUC).Org: University Hospitals Seidman Cancer Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Department of Medical Genetics, Cleveland, OH, Cancer Informatics,
Abstract
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.Org: Mayo Clinic, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Efficacy of checkpoint inhibitors in hospitalized patients with cancer.Org: Rutgers Health Community Medical Center, Monmouth Medical Center, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Real world outcomes of patients treated with first line chemo-immunotherapy (IO) for small cell lung cancer (SCLC): Impact of brain metastases and patterns of subsequent therapy.Org: The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, Ohio State University Comprehensive Canvcer Hospital, Adena Health System, The Ohio State College of Medicine, Center for Biostatistics and Department of Biomedical Informatics,
Abstract
Racial disparities in the outcomes of allogeneic bone marrow transplant: A 5-year nationwide inpatient study.Org: Albert Einstein College of Medicine, Jacobi Medical Center/North Central Bronx, Springfield Memorial Hospital, SIU School of Medicine, Montefiore Medical Center,
Abstract
Patterns of weight change and overall survival (OS) during first-line pembrolizumab treatment in patients with non-small cell lung cancer (NSCLC).Org: The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, James Cancer Hospital & Solove Research Institute, Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University College of Medicine, Ohio State University Wexner Medical Center,
Abstract
Integrated clinico-genomic characterization of pancreatic ductal adenocarcinoma in an Asian population.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea,
Abstract
Impacts of androgen pathway manipulation on patients with lung cancer.Org: Division of Chest Medicine, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Taichung Veterans General Hospital, Cancer Prevention and Control Center, Division of Critical Care and Respiratory Therapy,
Abstract
A population-level analysis of survival in patients with ALK+ anaplastic large cell lymphoma (ALCL) in the era of novel therapies.Org: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, Department of Translational Hematology and Oncology Research, Lerner Research Institute, Lerner Research Institute,
Abstract
Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care.Org: Montefiore Medical Center, Albert Einstein College of Medicine, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Bronx, NY, Montefiore Medical Center Wakefield Campus,
Abstract
Socioeconomic and demographic patterns associated with treatment delay in prostate cancer: An analysis of the National Cancer Database.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Creighton University School of Medicine Phoenix Regional Campus, St. Elizabeths Medical Center, Authority Health, Creighton Hematology Oncology, Omaha, NE,
Abstract
Socioeconomic and demographic factors on academic center accessibility in sebaceous adenocarcinoma: An NCDB analysis.Org: Creighton University School of Medicine Phoenix Regional Campus, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Utah,
Abstract
The role of ct-DNA in breast cancer surveillance assessing treatment response and recurrence: A community center experience.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Monmouth Medical Center, Long Branch, North Alabama Medical Center, Florence Nightingale Hospital,
Abstract
Real world outcome of neuroendocrine carcinomas of the bladder compared to conventional tumors of the bladder.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Cleveland Clinic Taussig Cancer Instititute, Glickman Urological and Kidney Institute, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Cleveland Clinic/Fairview Hospital,
Abstract
Late-stage prostate cancer and associated socioeconomic and demographic factors: A National Cancer Database Study.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Creighton University School of Medicine Phoenix Regional Campus, St. Elizabeths Medical Center, Creighton University Medical Center, Division of Hematology/Oncology, Department of Medicine, University Of Toledo,
Abstract
Clinical efficacy analysis of patients (pts) with HER-2 expressing metastatic urothelial carcinoma (mUC) treated with enfortumab vedotin (EV).Org: MD Anderson Hematology/Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Baylor College of Medicine, MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center,
Abstract
Incidence of central nervous system metastases (mCNS) and overall survival (OS) in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive chemoradiation followed by durvalumab (Durva).Org: Ohio State University Wexner Medical Center, Adena Health System, Center for Biostatistics and Department of Biomedical Informatics, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital & Solove Research Institute, Ohio State University James Cancer Hospital Department of Radiation Oncology,
Abstract
Impact of BAP1 mutational status on immunotherapy outcomes in advanced malignant pleural mesothelioma: A single institution experience.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Cleveland Clinic Taussig Cancer Instititute, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
Impact of a pathologist-driven molecular testing protocol on veterans with non-small cell lung cancer.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of California Irvine, Los Angeles Medical Center, West Los Angeles VA Health Care System, University of California Los Angeles Medical Center/Veterans Affairs,
Abstract
The effect of inflammatory-nutri̇tional prognosti̇c scori̇ng (INPS) system on treatment response and prognosi̇s i̇n pati̇ents wi̇th locally advanced gastroesophageal juncti̇on and gastri̇c cancer wi̇th neoadjuvant systemi̇c treatment.Org: Emory Winship Cancer Institute, Department of Engineering Sciences, Izmir Katip Celebi University, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Dokuz Eylul University Faculty of Medicine,
Abstract
Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma Org: Jacobi Medical Center/Albert Einstein College of Medicine, Universal College of Medical Sciences, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, UCSF Helen Diller Family Comp Cancer Ctr, Albert Einstein College of Medicine,
Abstract
Clinical outcomes of patients with multiple myeloma following disease progression after BCMA-targeted CAR T-cell therapy.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, UT Health Sciences Center at Houston, University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,
Abstract
The impact of cationic amphiphilic antihistamines on patients with lung cancer receiving immunotherapy.Org: National Taiwan University Hospital Yunlin Branch, Mount Auburn Hospital, Harvard Medical School, Unity Hospital, Rochester Regional Health System,
Abstract
Body image disturbances in adolescent and young adult patients with cancer confronting infertility risk and fertility preservation decisions.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Michigan, Rogel Cancer Center, University of Michigan School of Social Work, University of Pennsylvania,
Abstract
1,25(OH)2D AND IL-6 BLOCKADE SYNERGISTICALLY REGULATES RHEUMATOID ARTHRITIS VIA SUPPRESSION OF TH17 AND OSTEOCLASTOGENESISOrg: Seoul St Mary’s Hospital, College of Medicine, University of the Philippines - Manila, The Catholic University of Korea, Division Of Rheumatology, Department Of Internal Medicine, Toho University School Of Medicine, Tokyo, Japan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
18F-FDG-PET-POSITIVE TEMPORAL ARTERY IN GIANT CELL ARTERITIS: A POSSIBLE CORRELATION WITH HISTOPATHOLOGICAL FINDINGS Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan,
Abstract
A NEURAL NETWORK BASED CLUSTERING MODEL OF A COLOMBIAN COHORT OF RHEUMATOID ARTHRITIS PATIENTSOrg: University Hospital 12 de Octubre, School of Engineering Medicine，Beihang University, LISI research group, Reumavance research group, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
ABNORMAL CENTRAL RETINAL VEIN EQUIVALENT FOUND IN ACTIVE RHEUMATOID ARTHRITIS: A DIFFERENT PERSPECTIVE OF MICROVASCULAR HEALTH Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Department of Ophthalmology, Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey,